XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.2
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
 6 Months Ended
Jun. 30, 2019
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Six Months Ended
 
June 30, 2019
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by (used in) operating activities
$
4,904

 
$
128,070

 
$
(141,749
)
 
$
—

 
$
(8,775
)
Investing activities:

 

 

 

 

Capital expenditures
—

 
(5,843
)
 
(15,559
)
 
—

 
(21,402
)
Acquisition payments
—

 
(27,742
)
 
—

 
—

 
(27,742
)
Dividends received from subsidiaries
—

 
44,417

 
—

 
(44,417
)
 
—

Other
—

 
(192,235
)
 
(1,155
)
 
192,235

 
(1,155
)
Net cash used in investing activities
—

 
(181,403
)
 
(16,714
)
 
147,818

 
(50,299
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
147,818

 
242,134

 
720,657

 
(192,235
)
 
918,374

Repayments
—

 
(193,134
)
 
(525,306
)
 
—

 
(718,440
)
Repurchases of common stock
(152,722
)
 
—

 
—

 
—

 
(152,722
)
Dividends paid by subsidiaries
—

 
—

 
(44,417
)
 
44,417

 
—

Other
—

 
2,803

 
—

 
—

 
2,803

Net cash (used in) provided by financing activities
(4,904
)
 
51,803

 
150,934

 
(147,818
)
 
50,015

Effect of exchange rate changes on cash and cash equivalents
—

 
—

 
(66
)
 
—

 
(66
)
Net change in cash and cash equivalents
—

 
(1,530
)
 
(7,595
)
 
—

 
(9,125
)
Cash and cash equivalents at the beginning of period
—

 
35,931

 
60,412

 
—

 
96,343

Cash and cash equivalents at the end of period
$
—

 
$
34,401

 
$
52,817

 
$
—

 
$
87,218


 
Condensed Consolidating Statement of Cash Flows
 
Six Months Ended
 
June 30, 2018
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by operating activities
$
9,878

 
$
31,192

 
$
45,751

 
$
—

 
$
86,821

Investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
—

 
(9,334
)
 
(7,050
)
 
—

 
(16,384
)
Dividends received from subsidiaries
—

 
95,511

 
—

 
(95,511
)
 
—

Other
—

 
(37,524
)
 
(8,684
)
 
37,524

 
(8,684
)
Net cash provided by (used in) investing activities
—

 
48,653

 
(15,734
)
 
(57,987
)
 
(25,068
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
—

 
191,888

 
736,372

 
(45,511
)
 
882,749

Repayments
(7,987
)
 
(260,888
)
 
(673,761
)
 
7,987

 
(934,649
)
Repurchases of common stock
(1,891
)
 
—

 
—

 
—

 
(1,891
)
Dividends paid by subsidiaries
—

 
—

 
(95,511
)
 
95,511

 
—

Other
—

 
(9,958
)
 
—

 
—

 
(9,958
)
Net cash used in financing activities
(9,878
)
 
(78,958
)
 
(32,900
)
 
57,987

 
(63,749
)
Effect of exchange rate changes on cash and cash equivalents
—

 
—

 
(5,017
)
 
—

 
(5,017
)
Net change in cash and cash equivalents
—

 
887

 
(7,900
)
 
—

 
(7,013
)
Cash and cash equivalents at the beginning of period
—

 
50,602

 
67,351

 
—

 
117,953

Cash and cash equivalents at the end of period
$
—

 
$
51,489

 
$
59,451

 
$
—

 
$
110,940